Frequency of Hepatocellular Carcinoma in Patients Infected with Hepatitis C Virus visiting a Tertiary Care Hospital in Lahore for Computed Tomographic Evaluation

Nozaina Irum, Muhammad Zakir, Imran Yousaf, Muhammad Yousaf Farooq, Amna Akhtar, Sidra Mehmood, Saleha Tariq, Fakher Un Nisa Bhatti, Rija Zaigham, Zareen Fatima

Abstract


Background: Hepatitis C virus has been identified as one of the leading causes of chronic liver disease and its complications world-wide. Subsequent development of hepatocellular carcinoma in these patients is a major complication of this infection having serious implications on morbidity and mortality rates. The objective of this study was to find out the frequency of Hepatocellular carcinoma in patients suffering from Hepatitis C visiting Radiology department of a tertiary care hospital for multi-detector computed tomography evaluation.

Methods: This cross-sectional analytical study was conducted at Shalamar Hospital Lahore. A total of 195 patients, suffering from Hepatitis C, visiting Shalamar Hospital, Lahore for evaluation by CT during 6 months study interval were included in this study. Abdominal CT was performed using Triphasic contrast enhancement protocol. All images were interpreted by a senior Radiologist. Frequency of Hepatocellular carcinoma was calculated. Statistical analysis was made using MEDCALC.

Results: Out of 195, 63(32.3%) patients were seen to have hepatocellular carcinoma. This disease was more common in male, 45(34.6%) as compared to female patients 18 (27.7%). The presence of HCC showed statistically significant association with alcoholism, obesity, diabetes mellitus and cirrhosis.

Conclusion: The study concluded that a substantial number of HCV positive patients develop HCC, which is more common in men as compared to women. The presence of HCC is strongly associated with alcoholism, obesity, diabetes mellitus and cirrhosis.

Keywords: Hepatocellular carcinoma (HCC); Hepatitis C (HCV); Multi-detector Computed Tomography (MDCT) 


Full Text:

PDF

References


Yousaf MZ, Idrees M, Saleem Z, Rehman IU, Ali M. Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan. Virology Journal, (2011); 8: 1–7.

Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, et.al. Hepatitis C virus infection in children and adolescents. The lancet Gastroenterology & Hepatology, (2019); 4(6): 477–87.

Ali Q, Jamal A, Imran M, Ullah S, Kalam I, et.al. Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study. Personalized Medicine, (2018); 15(6): 495–502.

Lubner MG, Jones D, Said A, Kloke J, Lee S, et.al. Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdominal Radiology, (2018); 43(11): 2980–6.

Axley P, Ahmed Z, Ravi S, Singal AK. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review. Journal of Clinical and Translational Hepatology, (2018); 6(1): 79–84.

Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. Journal of carcinogenesis, (2017); 16: 1.

Hafeez M, Nadeem M, Ahmed M. Hepatocellular Carcinoma (HCC), Where do we stand? Current situation. Pakistan Journal of Medical Sciences, (2020); 36(3): 344-348.

Lee KH, O’Malley ME, Haider MA, Hanbidge A. triple-phase MDCT of hepatocellular carcinoma. American Journal of Roentgenology, (2004); 182(3): 643-9.

Muhi A, Ichikawa T, Motosugi U, Sano K, Fatima Z, et.al. Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatology International, (2013); 7(2): 662–8.

Idrees M, Rafique S, Rehman I, Akbar H, Yousaf MZ, et.al. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World Journal of Gastroenterology, (2009); 15(40): 5080–5.

Parkash O, Hamid S. Next big threat for Pakistan hepatocellular carcinoma (HCC). Journal of Pakistan Medical Association, (2016); 66(6): 735.

de Martel C, Maucort‐Boulch D, Plummer M, Franceschi S. World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology, (2015); 62(4): 1190–200.

Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World Journal of Gastroenterology, (2003); 9(3): 385–91

Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best practice & research Clinical gastroenterology, (2014); 28(5): 753–70.

Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, et.al. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Epidemiology & Infection, (1996); 117: 327–332.

Abdul Mujeeb S, Jamal Q, Khanani R, Iqbal N, Kaher S. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan. Tropical Doctor, (1997); 27: 45–46

Butt AS, Hamid S, Wadalawala AA, Ghufran M, Javed AA, et.al. Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma. BMC research notes, (2013); 6(1): 1–3.

Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology, (1995); 21(3): 650–5.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, et.al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer, (1999); 85(10): 2132–7.

Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, et.al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. British Journal of Cancer, (1997); 76(7): 968-74.

Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, et.al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer, (1994); 74(9): 2442-8.

Haqqi A, Munir R, Khalid M, Khurram M, Zaid M, et.al. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral immunology, (2019); 32(9): 402-13.

Idrees M, Rafique S, Rehman IU, Akbar H, Yousaf MZ, et.al. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World Journal of Gastroenterology: WJG, (2009); 15(40): 5080.

Abideen ZU, Siddique S, Nasrullah I, Khan JS, Rehman S, et.al. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients. European Journal of Gastroenterology & Hepatology, (2019); 31(9):1103-9.

Rasheed A, Ullah S, Naeem S, Zubair M, Ahmad W, et.al. Occurrence of HCV genotypes in different age groups of patients from Lahore, Pakistan. Advancements in life Sciences, (2014); 1(2): 89-95.

Ali A, Nisar M, Ahmad H, Saif N, Idrees M, et.al. Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virology journal, (2011); 8(1): 1-6.

Schütte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma–epidemiological trends and risk factors. Digestive diseases, (2009); 27(2): 80-92.




DOI: http://dx.doi.org/10.62940/als.v9i2.1421

Refbacks

  • There are currently no refbacks.